Executive Briefing Series (formerly The Food & Drug Letter)

Oct. 5, 2012

FDA: Submit Launch Promotions Early for Accelerated Approval Drugs

Drugmakers with drugs or biologics under FDA review for accelerated approval should submit promotional materials to the agency while the drug is under review if they plan to use the launch materials within 120 days of approval.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives

FDA to Launch Physician Survey of DTC Rx Drug Marketing Par Needs Compliance Officer, Compliance Committee, CIA Says Par CIA Calls for Compliance Officer, Compliance Committee OPDP Spreads DTC, Professional Ad Reviews to Both Divisions

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.